| - GRCh37:
- Chr6:45649408-54076842
- GRCh38:
- Chr6:45681671-54212044
| ADGRF1, ADGRF2, ADGRF4, ADGRF5, ADGRF5-AS1, ANKRD66, C6orf141, CD2AP, CENPQ, CILK1, CLIC5, CRISP1, CRISP2, CRISP3, CYP39A1, DEFB110, DEFB112, DEFB113, DEFB114, EFHC1, ELOVL5, ENPP4, ENPP5, FBXO9, GCLC, GCLC-AS1, GCM1, GLYATL3, GSTA1, GSTA2, GSTA3, GSTA4, GSTA5, IL17A, IL17F, KILH, KLHL31, LINC01564, LINCMD1, LOC101926915, LOC101927020, LOC101927048, LOC101927082, LOC101927189, LOC110120617, LOC110120792, LOC110121112, LOC110121250, LOC111365194, LOC111429620, LOC113175006, LOC113175007, LOC114004401, LOC114004402, LOC116183064, LOC121132687, LOC121132688, LOC121740649, LOC121740650, LOC121740651, LOC121740652, LOC123744814, LOC123744815, LOC123744816, LOC123744817, LOC123744818, LOC123744819, LOC123744820, LOC123744821, LOC123744822, LOC123744823, LOC123744824, LOC123744825, LOC123744826, LOC123744827, LOC123744828, LOC126859682, LOC126859683, LOC126859684, LOC126859685, LOC126859686, LOC126859687, LOC126859688, LOC126859689, LOC126859690, LOC126859691, LOC126859692, LOC126859693, LOC126859694, LOC126859695, LOC126859696, LOC126859697, LOC128031835, LOC128092246, LOC730101, LRRC1, MCM3, MEP1A, MIR133B, MIR206, MIR5685, MLIP, MLIP-AS1, MLIP-IT1, MMUT, OPN5, PAQR8, PGK2, PKHD1, PLA2G7, PTCHD4, RCAN2, RCAN2-DT, RHAG, RN7SK, SLC25A27, TDRD6, TDRD6-AS1, TFAP2B, TFAP2D, TMEM14A, TNFRSF21, TRAM2, TRAM2-AS1 | | See cases | Pathogenic (Aug 20, 2012) | no assertion criteria provided |
| - GRCh37:
- Chr6:47159515-51292104
- GRCh38:
- Chr6:47191779-51427306
| C6orf141, CD2AP, CENPQ, CRISP1, CRISP2, CRISP3, DEFB110, DEFB112, DEFB113, DEFB114, GLYATL3, LOC101927020, LOC101927048, LOC110120617, LOC110120792, LOC111429620, LOC114004402, LOC116183064, LOC121132687, LOC121740649, LOC123744815, LOC123744816, LOC123744817, LOC123744818, LOC123744819, LOC126859685, LOC126859686, LOC126859687, LOC126859688, LOC126859689, MMUT, OPN5, PGK2, PTCHD4, RHAG, TFAP2B, TFAP2D, TNFRSF21, ADGRF2, ADGRF4 | | See cases | Likely pathogenic (Mar 24, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr6:50786571
- GRCh38:
- Chr6:50818858
| TFAP2B | | Char syndrome, not provided | Benign (Sep 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:50786607
- GRCh38:
- Chr6:50818894
| TFAP2B | M1I | Craniosynostosis syndrome | Likely pathogenic (Jul 23, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:50786652
- GRCh38:
- Chr6:50818939
| TFAP2B | | not provided | Likely benign (May 15, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50791110
- GRCh38:
- Chr6:50823397
| TFAP2B | | not provided | Likely benign (May 15, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50791116
- GRCh38:
- Chr6:50823403
| TFAP2B | | not provided | Likely benign (Mar 30, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50791128
- GRCh38:
- Chr6:50823415
| TFAP2B | | not provided | Likely benign (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50791130
- GRCh38:
- Chr6:50823417
| TFAP2B | D31G | not provided | Uncertain significance (Dec 11, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50791135
- GRCh38:
- Chr6:50823422
| TFAP2B | V33I | not provided | Uncertain significance (Mar 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50791154
- GRCh38:
- Chr6:50823441
| TFAP2B | R39P | not provided | Uncertain significance (Oct 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50791199
- GRCh38:
- Chr6:50823486
| TFAP2B | A54G | not provided | Uncertain significance (Nov 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50791217
- GRCh38:
- Chr6:50823504
| TFAP2B | T60N | not provided | Uncertain significance (Feb 12, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50791237
- GRCh38:
- Chr6:50823524
| TFAP2B | P67S | not provided | Uncertain significance (Jan 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50791256
- GRCh38:
- Chr6:50823543
| TFAP2B | P73R | Char syndrome | Pathogenic (Oct 1, 2001) | no assertion criteria provided |
| - GRCh37:
- Chr6:50791290
- GRCh38:
- Chr6:50823577
| TFAP2B | | not provided | Benign (Oct 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50791310-50791311
- GRCh38:
- Chr6:50823597-50823598
| TFAP2B | Y93fs | not provided | Pathogenic (Jul 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50791446
- GRCh38:
- Chr6:50823733
| TFAP2B | D136E | not provided | Uncertain significance (Sep 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50791446
- GRCh38:
- Chr6:50823733
| TFAP2B | D136E | not provided | Uncertain significance (Jan 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50791456
- GRCh38:
- Chr6:50823743
| TFAP2B | D140H | not provided | Uncertain significance (Jun 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50791472-50791475
- GRCh38:
- Chr6:50823759-50823762
| TFAP2B | P147fs | Patent ductus arteriosus 2 | Pathogenic (Oct 17, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr6:50791482
- GRCh38:
- Chr6:50823769
| TFAP2B | D148E | Char syndrome | not provided | no assertion provided |
| - GRCh37:
- Chr6:50791515
- GRCh38:
- Chr6:50823802
| TFAP2B | | not provided | Likely benign (Aug 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50791560
- GRCh38:
- Chr6:50823847
| TFAP2B | | not provided | Likely benign (Aug 16, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50791575
- GRCh38:
- Chr6:50823862
| TFAP2B | | not provided | Likely benign (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50791578
- GRCh38:
- Chr6:50823865
| TFAP2B | | not provided | Uncertain significance (Feb 10, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50791584-50791585
- GRCh38:
- Chr6:50823871-50823872
| TFAP2B | | not provided, Char syndrome | Conflicting interpretations of pathogenicity (Oct 9, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:50791585-50791592
- GRCh38:
- Chr6:50823872-50823879
| TFAP2B | | not provided | Benign (Oct 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50791585-50791588
- GRCh38:
- Chr6:50823872-50823875
| TFAP2B | | not specified, not provided, Char syndrome
| Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:50791588
- GRCh38:
- Chr6:50823875
| TFAP2B | | not specified | Benign | criteria provided, single submitter |
| - GRCh37:
- Chr6:50791592
- GRCh38:
- Chr6:50823879
| TFAP2B | | not provided | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:50791640
- GRCh38:
- Chr6:50823927
| TFAP2B | | not provided | Benign (May 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50796329-50796332
- GRCh38:
- Chr6:50828616-50828619
| TFAP2B | | not provided | Uncertain significance (May 23, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50796330
- GRCh38:
- Chr6:50828617
| TFAP2B | | Patent ductus arteriosus 2 | Pathogenic (Oct 17, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr6:50796353
- GRCh38:
- Chr6:50828640
| TFAP2B | S188G | not provided, Inborn genetic diseases | Conflicting interpretations of pathogenicity (Dec 15, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:50796393
- GRCh38:
- Chr6:50828680
| TFAP2B | | Inborn genetic diseases | Pathogenic (May 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50796394
- GRCh38:
- Chr6:50828681
| TFAP2B | | Craniosynostosis syndrome | Likely pathogenic (Jul 23, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:50796397
- GRCh38:
- Chr6:50828684
| TFAP2B | | Patent ductus arteriosus 2, Char syndrome | Pathogenic (Feb 22, 2005) | no assertion criteria provided |
| - GRCh37:
- Chr6:50796407
- GRCh38:
- Chr6:50828694
| TFAP2B | | not provided | Likely benign (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50796634
- GRCh38:
- Chr6:50828921
| TFAP2B | | not provided | Benign (Nov 12, 2018) | criteria provided, single submitter |
| - GRCh38:
- Chr6:50836056-50836065
| TFAP2B | | Chronic intestinal pseudoobstruction | Pathogenic (May 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50803785
- GRCh38:
- Chr6:50836072
| TFAP2B | P205S | not provided | Uncertain significance (Oct 30, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50803821
- GRCh38:
- Chr6:50836108
| TFAP2B | G217fs | Char syndrome | Pathogenic (Nov 14, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50803842
- GRCh38:
- Chr6:50836129
| TFAP2B | V224I | Inborn genetic diseases, not provided | Uncertain significance (Jul 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:50803863
- GRCh38:
- Chr6:50836150
| TFAP2B | C231R | not provided | Uncertain significance (Jul 26, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50803878
- GRCh38:
- Chr6:50836165
| TFAP2B | R236S | Char syndrome | Pathogenic (Oct 1, 2001) | no assertion criteria provided |
| - GRCh37:
- Chr6:50803878
- GRCh38:
- Chr6:50836165
| TFAP2B | R236C | Char syndrome | Pathogenic (Oct 1, 2001) | no assertion criteria provided |
| - GRCh37:
- Chr6:50803879
- GRCh38:
- Chr6:50836166
| TFAP2B | R236H | Char syndrome | Likely pathogenic (Oct 22, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr6:50803892
- GRCh38:
- Chr6:50836179
| TFAP2B | | not provided | Likely benign (Apr 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50803944
- GRCh38:
- Chr6:50836231
| TFAP2B | S258A | Char syndrome | not provided | no assertion provided |
| - GRCh37:
- Chr6:50803973
- GRCh38:
- Chr6:50836260
| TFAP2B | | not provided | Likely benign (Oct 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50804008-50804013
- GRCh38:
- Chr6:50836295-50836300
| TFAP2B | | not provided | Likely benign (Sep 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50805687
- GRCh38:
- Chr6:50837974
| TFAP2B | | Char syndrome | not provided | no assertion provided |
| - GRCh37:
- Chr6:50805690
- GRCh38:
- Chr6:50837977
| TFAP2B | A275D | Char syndrome | Pathogenic (Nov 20, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50805693
- GRCh38:
- Chr6:50837980
| TFAP2B | K276R | Craniosynostosis syndrome | Likely pathogenic (Jul 23, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:50805696
- GRCh38:
- Chr6:50837983
| TFAP2B | S277W | Char syndrome, Bifid nasal tip, Upslanted palpebral fissure, Hypertelorism, Clinodactyly of the 5th finger, Opacification of the corneal stroma
| Uncertain significance (Nov 19, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:50805720
- GRCh38:
- Chr6:50838007
| TFAP2B | R285Q | not provided, Char syndrome | Pathogenic/Likely pathogenic (Dec 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:50805727
- GRCh38:
- Chr6:50838014
| TFAP2B | R287S | not specified | Uncertain significance (May 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50805764
- GRCh38:
- Chr6:50838051
| TFAP2B | R300C | Char syndrome | Pathogenic (May 1, 2000) | no assertion criteria provided |
| - GRCh37:
- Chr6:50805783
- GRCh38:
- Chr6:50838070
| TFAP2B | T306M | Char syndrome | Uncertain significance (Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:50805942
- GRCh38:
- Chr6:50838229
| TFAP2B | | not provided | Benign (Nov 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50807897
- GRCh38:
- Chr6:50840184
| TFAP2B | F323L | Inborn genetic diseases | Uncertain significance (Nov 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50807899
- GRCh38:
- Chr6:50840186
| TFAP2B | G324A | not provided | Uncertain significance (Mar 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50807910
- GRCh38:
- Chr6:50840197
| TFAP2B | E328Q | Inborn genetic diseases | Uncertain significance (Apr 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50807925
- GRCh38:
- Chr6:50840212
| TFAP2B | A333S | not provided | Likely benign (Oct 11, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50807933
- GRCh38:
- Chr6:50840220
| TFAP2B | | not provided | Likely benign (Jul 16, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50807934
- GRCh38:
- Chr6:50840221
| TFAP2B | V336I | not provided | Benign (Jan 17, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50807966
- GRCh38:
- Chr6:50840253
| TFAP2B | D346E | not provided | Uncertain significance (Mar 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50810497
- GRCh38:
- Chr6:50842784
| TFAP2B | | not provided | Benign (Nov 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50810826
- GRCh38:
- Chr6:50843113
| TFAP2B | | not provided | Benign (Aug 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50810827
- GRCh38:
- Chr6:50843114
| TFAP2B | D369H | Char syndrome | Uncertain significance (Feb 13, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50810838
- GRCh38:
- Chr6:50843125
| TFAP2B | | not provided | Likely benign (Nov 14, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50810866
- GRCh38:
- Chr6:50843153
| TFAP2B | R382* | Craniosynostosis syndrome | Likely pathogenic (Jul 23, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:50810881
- GRCh38:
- Chr6:50843168
| TFAP2B | | not provided | Benign (Aug 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50810915
- GRCh38:
- Chr6:50843202
| TFAP2B | F398S | not provided | Uncertain significance (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50810964
- GRCh38:
- Chr6:50843251
| TFAP2B | | not provided | Likely benign (Jul 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50810967
- GRCh38:
- Chr6:50843254
| TFAP2B | | not provided | Likely benign (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50811011
- GRCh38:
- Chr6:50843298
| TFAP2B | K430M | not provided | Uncertain significance (Dec 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50811024
- GRCh38:
- Chr6:50843311
| TFAP2B | N434K | Char syndrome, Patent ductus arteriosus 2 | Uncertain significance (Jun 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50811026
- GRCh38:
- Chr6:50843313
| TFAP2B | N435T | not provided, Inborn genetic diseases | Conflicting interpretations of pathogenicity (Oct 24, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:50811039
- GRCh38:
- Chr6:50843326
| TFAP2B | | not provided | Likely benign (Feb 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50811115
- GRCh38:
- Chr6:50843402
| TFAP2B | | not specified, not provided | Benign (May 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:50811120-50811122
- GRCh38:
- Chr6:50843407-50843409
| TFAP2B | | Char syndrome | Likely benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50811238
- GRCh38:
- Chr6:50843525
| TFAP2B | | not provided | Benign (May 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50811238-50811239
- GRCh38:
- Chr6:50843525-50843526
| TFAP2B | | Char syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50811241
- GRCh38:
- Chr6:50843528
| TFAP2B | | not provided | Benign (May 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50811283
- GRCh38:
- Chr6:50843570
| TFAP2B | | not provided | Benign (May 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50812004-50812005
- GRCh38:
- Chr6:50844291-50844292
| TFAP2B | | Char syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50812004
- GRCh38:
- Chr6:50844291
| TFAP2B | | not provided, Char syndrome | Conflicting interpretations of pathogenicity (May 17, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:50812015
- GRCh38:
- Chr6:50844302
| TFAP2B | | not provided | Benign (May 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50812015-50812016
- GRCh38:
- Chr6:50844302-50844303
| TFAP2B | | Char syndrome, not provided | Conflicting interpretations of pathogenicity (May 15, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:50812015-50812016
- GRCh38:
- Chr6:50844302-50844303
| TFAP2B | | Char syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50812015-50812019
- GRCh38:
- Chr6:50844302-50844306
| TFAP2B | | Char syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50812016-50812019
- GRCh38:
- Chr6:50844303-50844306
| TFAP2B | | Char syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50812016-50812017
- GRCh38:
- Chr6:50844303-50844304
| TFAP2B | | Char syndrome, not provided | Conflicting interpretations of pathogenicity (May 16, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:50812017
- GRCh38:
- Chr6:50844304
| TFAP2B | | not provided | Benign (May 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50812017-50812021
- GRCh38:
- Chr6:50844304-50844308
| TFAP2B | | Char syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50812530
- GRCh38:
- Chr6:50844817
| TFAP2B | | Char syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50812748
- GRCh38:
- Chr6:50845035
| TFAP2B | | Char syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr6:50813038-50813039
- GRCh38:
- Chr6:50845325-50845326
| TFAP2B | | Char syndrome | Likely benign (Jun 14, 2016) | criteria provided, single submitter |